When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very common and because the hepatitis C virus had not yet been discovered. I ...
The worldwide outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the novel pathogen responsible for the coronavirus disease 2019 (COVID-19) pandemic, has stimulated intensive ...
A new compound that inhibits the replication of hepatitis C virus (HCV) in several stages of its lifecycle - and is also capable of acting on bacteria, fungi and cancer cells - has been synthesized by ...
A paper in Nature also found that interferon beta reduced the expression of miR-122, essential for HCV replication. miRNAs expressed by interferon beta, the only approved therapy for hepatitis C, are ...
Researchers from UCLA's Jonsson Comprehensive Cancer Center have identified a cell-permeable peptide that inhibits a hepatitis C virus protein and blocks viral replication, which can lead to liver ...
Anna Suk-Fong Lok has served on advisory panels of Roche, Viravaxx, and Spring Bank. She receives research funding from Bristol-Myers Squibb, Gilead, the National Institutes of Health, and the Patient ...
Anna Suk-Fong Lok has served on advisory panels of Roche, Viravaxx, and Spring Bank. She receives research funding from Bristol-Myers Squibb, Gilead, the National Institutes of Health, and the Patient ...
When I began my medical career in Hong Kong in the early 1980s, I chose to focus on hepatitis B, in part because it was very common and because the hepatitis C virus had not yet been discovered. I ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback